Elderly patients with glioblastoma: The treatment challenge

Expert Review of Neurotherapeutics

Volumn 13, Issue 10, 2013, Pages 1099-1105

  Fiorentino, Alba ^a   Bonis, Pasquale De ^b   Chiesa, Silvia ^c   Balducci, Mario ^c   Fusco, Vincenzo ^a  

^a REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^b S ANNA HOSPITAL   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

elderly patients; glioblastoma; radiochemotherapy; surgery; temozolomide

Indexed keywords

TEMOZOLOMIDE;

AGING; CANCER GRADING; CANCER MORTALITY; CHARLSON COMORBIDITY INDEX; CHEMORADIOTHERAPY; CLINICAL EVALUATION; COMORBIDITY; GERIATRIC ASSESSMENT; GLIOBLASTOMA; HUMAN; IRRADIATION; KARNOFSKY PERFORMANCE STATUS; LIFESPAN; MOLECULAR BIOLOGY; NEUTROPENIA; OVERALL SURVIVAL; PATIENT COMPLIANCE; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; REVIEW; THROMBOCYTOPENIA;

AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; GLIOBLASTOMA; HUMANS; PROGNOSIS;

EID: 84886876599     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.2013.840419     Document Type: Review

References (48)

1. Stupp R, Mason WP, van den Bent MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352(10), 987-996 (2005). (Pubitemid 40349501)
2. Brandes AA, Bartolotti M. Treatment decision in elderly patients with glioblastoma. Nat. Rev. Neurol. 8, 664-665 (2012).
3. Nghiemphu PL, Cloughesy T. Glioblastoma therapy in the elderly: one age does not fit all. Lancet Oncol. 13, 857-858 (2012).
4. Fiorentino A, Balducci M, Chiesa S, Fusco V. Elderly people with glioblastoma. Lancet Oncol. 13, e327-e328 (2012).
5. Yovino S, Grossman SA. Treatment of glioblastoma in 'elderly' patients. Curr. Treat. Opin. Oncol. 12, 253-262 (2011).
6. Iwamoto FM, Cooper AR, Reiner AS et al. Glioblastoma in elderly: the Memorial-Sloan Kettering Cancer Center experience (1997-2007). Cancer 115(16), 3758-3766 (2009).
7. Sahebjam S, McNamara M, Mason WP. Management of glioblastoma in the elderly. Clin. Adv. Hematol. Oncol. 10, 379-386 (2012).
8. Balducci M, Fiorentino A, De Bonis P et al. Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional Phase II studies. Med. Oncol. 29(5), 3478-3483 (2012).
9. Fiorentino A, Caivano R, Chiumento C et al. Comorbidity assessment and adjuvant radiochemotherapy in elderly affected by glioblastoma. Med. Oncol. 29(5), 3467-3471 (2012).
10. de Barros Pontes L, Karnakis T, Fleury Malheiros SM et al. Glioblastoma: approach to treat elderly patients. Einstein 10(4), 512-518 (2012).
11. Mangiola A, De Bonis P, Guerriero M, Popucci A, Anile C. Glioblastoma multiforme in the elderly: a therapeutic challenge. J. Neurooncol. 76(2), 159-163 (2006). (Pubitemid 43125743)
12. Ewelt C, Goeppert M, Rapp M, Steiger HJ, Stummer W, Sabel M. Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival. J. Neurooncol. 103(3), 611-618 (2011).
13. Wick W, Platten M, Meisner C et al. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, Phase 3 trial. Lancet Oncol. 13, 707-715 (2012).
14. Scott J, Tsai YY, Chinnaiyan P, Yu HH. Effectiveness of radiotherapy for elderly patients with glioblastoma. Int. J. Rad. Oncol. Biol. Phys. 81(1), 206-210 (2011).
15. Keim-Guibert F, Chinot O, Taillandier L et al. Radiotherapy for glioblastoma in elderly. N. Engl. J. Med. 356, 1527-1535 (2007).
16. Bauman GS, Gaspar LE, Fisher BJ et al. A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys. 29, 835-839 (1994). (Pubitemid 24241325)
17. Roa W, Brasher PM, Bauman G et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J. Clin. Oncol. 22(9), 1593-1598 (2004).
18. Lawrence YR, Li Xa, el Naga I et al. Radiation dose-volume effect in the brain. Int. J. Radiat. Oncol. Biol. Phys. 76, S20-27 (2010).
19. Galanis E, Buckner J. Chemotherapy for high-grade gliomas. Br. J. Cancer 82, 1371-1380 (2000). (Pubitemid 30175900)
20. Fine HA, Dear KBG, Loeffler JS, Black PM, Canellos GP. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71, 2585-2597 (1993). (Pubitemid 23100496)
21. Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359, 1011-1018 (2002). (Pubitemid 34286538)
22. Hirose Y, Berger MS, Pieper RO. P53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells. Cancer. Res. 61, 1957-1963 (2001). (Pubitemid 32692013)
23. Chamberlain MC, Chalmers L. A pilot study of primary temozolomide chemotherapy and deferred radiotherapy in elderly patients with glioblastoma. J. Neurooncol. 82, 207-209 (2007). (Pubitemid 46431867)
24. Laigle-Donadey F, Figarella-Branger D, Chinot O et al. Up-front temozolomide in elderly patients with glioblastoma. J. Neurooncol. 99, 89-94 (2010).
25. Chinot OL, Barrie M, Barrie M et al. Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations. Cancer 100(10), 2208-2214 (2004).
26. Gallego-Perez-Larraya J, Ducray F, Chinot O et al. Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF Phase II trial. J. Clin. Oncol. 29, 3050-3055(2011).
27. Chargari C, Feuvret L, Bauduceau O et al. Treatment of elderly patients with glioblastoma: from clinical evidence to molecular highlights. Cancer Treat. Rev. 38, 988-995 (2012).
28. Glantz M, Chamberlain M, Liu Q et al. Temozolomide as an alternative to irradiation for elderly patients with new diagnosed malignant gliomas. Cancer 97(9), 2262-2266 (2003). (Pubitemid 36444070)
29. Malmstrom A, Gronberg BH, Marosi C et al. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, Phase 3 trial. Lancet Oncol. 13, 916-926 (2012).
30. De Bonis P, Mangiola A, Pompucci A, Porso M, Anile C. High-grade glioma: elderly patients, older treatments. Expert Rev. Neurother. 12(11), 1293-1296 (2012).
31. Stupp R, Hegi ME, Mason WP et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised Phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 10, 459-466 (2009).
32. Floyd SR, Kasper EM, Uhlmann EJ et al. Hypofractionated radiotherapy and stereotactic boost with concurrent and adjuvant temozolomide for glioblastoma in glioblastoma status elderly patients-early results of a phase II trial. Front Oncol. 2, 122 (2012).
33. Fiorentino A, Balducci M, De Bonis P et al. Can elderly patients with newly diagnosed glioblastoma be enrolled in radiochemotherapy trials? Am. J. Clin. Oncol. doi:10.1097/COC.0b013e3182868ea2 (2013) (Epub ahead of print).
34. Fiorentino A, Chiumento C, Caivano R et al. Adjuvant radiochemotherapy in the elderly affected by glioblastoma: single-institution experience and literature review. Radiol. Med. 118(5), 870-881 (2012).
35. Combs SE, Wagner J, Bischof M et al. Postoperative treatment of primary gioblastoma multiforme with radiation and concomitant temozolomide in elderly patients. Int. J. Radiat. Oncol. Biol. Phys. 70, 987-992 (2008). (Pubitemid 351296114)
36. Minniti G, De Sanctis V, Muni R et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. J. Neurooncol. 88, 97-103 (2008).
37. Brandes AA, Franceschi E, Tosoni A et al. Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. Cancer 115, 3512-3518 (2009).
38. Gerstein J, Franz K, Steinbach JP et al. Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma. Radiother. Oncol. 97(3), 382-386 (2010).
39. Fiorica F, Berretta M, Colosimo C et al. Glioblastoma in elderly patients: safety and efficacy of adjuvant radiotherapy with concomitant temozolomide. Arch. Gerontol. Geriatr. 51(1), 31-35 (2010).
40. Kimple RJ, Grabowski S, Papez M, Collichio F, Ewend MG, Morris DE. Concurrent temozolomide and radiation, a reasonable option for elderly patients with glioblastoma multiforme? Am. J. Clin. Oncol. 33, 265-270 (2010).
41. Dirier A, Abacioglu MU, Okkan S et al. Radiotherapy with or without temozolomide in elderly glioblastoma patients: treatment results and prognostic factor. J. Clin. Oncol. 28, 15s (2010).
42. Minniti G, Lanzetta G, Scaringi C et al. Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma. Int. J. Radiat. Oncol. Biol. Phys. 83, 93-99 (2012).
43. Cao JQ, Fisher BJ, Bauman GS, Megyesi JF, Watling CJ, Macdonald DR. Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience. J. Neurooncol. 107, 395-405 (2012).
44. Soussain C, Ricard D, Fike JR, Mazeron JJ, Psimaras D, Delattre JY. CNS complications of radiotherapy and chemotherapy. Lancet 374, 1639-1651 (2009).
45. Brown PD, Jensen AW, Felten SJ et al. Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma. J. Clin. Oncol. 24, 5427-5433 (2006). (Pubitemid 46623176)
46. Balducci M, Chiesa S, Diletto B et al. Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study. Neuro. Oncol. 14(1), 79-86 (2012).
47. Holdhoff M, Rosner GL, Alcorn S, Grossman SA. 'Elderlyrsquo; patients with newly diagnosed glioblastoma deserve optimal care. J. Neurooncol. 113(2), 343-344 (2013).
48. Fiorentino A, Fusco V. Elderly patients affected by glioblastoma treated with radiotherapy: the role of serum hemoglobin level. Int. J. Neurosci. 123(2), 133-137 (2013).